The email is one reason why GSK decided today — 11 years after Garnier raised the issue with his staff — to settle about 10,000 cases for $46,000 apiece. The FDA is reviewing the drug’s record for heart attacks and other cardiovascular problems; it will probably be withdrawn from the market or the terms of its use will be severely restricted.
So Garnier and Glaxo knew in 1999 that Avandia was a killer – but it didn’t stop them pushing the drug for 11 more years.
The next thing we need to know is just what data did Glaxo supply in order to get Avandia licenced by the MHRA and FDA?
How did Glaxo manage to pull the wool over the regulators’ eyes?
I’m just asking….